Capula Management Ltd bought a new position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 11,627 shares of the biotechnology company’s stock, valued at approximately $1,409,000. Other hedge funds and other institutional investors have also modified their holdings of […]
With U.S. stock markets set to open in two hours, (JNPR) was up 23.8% in pre-market trading, and (MTCH) was up 15.1%. (SRPT), (TENB), and (EXEL) were all.
Eagle Health Investments LP raised its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 79.0% during the third quarter, Holdings Channel reports. The institutional investor owned 174,212 shares of the biotechnology company’s stock after buying an additional 76,872 shares during the period. Sarepta Therapeutics makes up about 4.7% of Eagle Health Investments LP’s […]
Eagle Health Investments LP grew its stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 79.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 174,212 shares of the biotechnology company’s stock after buying an additional 76,872 […]